Jeremy Grantham Pacific Biosciences Of California, Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$4.6 - $5.57 $8.33 Million - $10.1 Million	-1,810,217 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$4.99 - $6.16 $3.81 Million - $4.7 Million	763,574 Added 72.95%	1,810,217 $9.34 Million
Q2 2019 Aug 13, 2019	BUY	$5.92 - $7.41 $6.2 Million - $7.76 Million	1,046,643 New	1,046,643 $6.33 Million
Q1 2019 May 14, 2019	SELL	$6.8 - $7.4 $216,920 - $236,060	-31,900 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$3.99 - $7.82 $127,281 - $249,458	31,900 New	31,900 $236,000

255

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $429M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.